par Alberti, Luca;Torlasco, C;Lauretta, Ludovica 
;Loffi, M;Maranta, F;Salonia, Andrea;Margonato, Alberto;Montorsi, Francesco;Fragasso, Gabriele
Référence Andrology, 1, 2, page (177-191)
Publication Publié, 2013-03
;Loffi, M;Maranta, F;Salonia, Andrea;Margonato, Alberto;Montorsi, Francesco;Fragasso, GabrieleRéférence Andrology, 1, 2, page (177-191)
Publication Publié, 2013-03
Article révisé par les pairs
| Titre: |
|
| Auteur: | Alberti, Luca; Torlasco, C; Lauretta, Ludovica; Loffi, M; Maranta, F; Salonia, Andrea; Margonato, Alberto; Montorsi, Francesco; Fragasso, Gabriele |
| Informations sur la publication: | Andrology, 1, 2, page (177-191) |
| Statut de publication: | Publié, 2013-03 |
| Sujet CREF: | Sciences bio-médicales et agricoles |
| MeSH keywords: | Adrenergic beta-Antagonists -- adverse effects -- therapeutic use |
| Cardiovascular Agents -- adverse effects -- therapeutic use | |
| Cyclic Nucleotide Phosphodiesterases, Type 5 | |
| Erectile Dysfunction -- complications | |
| Exercise Tolerance | |
| Heart Failure -- drug therapy -- etiology | |
| Humans | |
| Male | |
| Penile Erection | |
| Phosphodiesterase 5 Inhibitors -- therapeutic use | |
| Sexual Behavior | |
| Sodium Chloride Symporter Inhibitors -- adverse effects -- therapeutic use | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:2047-2919 |
| info:doi/10.1111/j.2047-2927.2012.00048.x | |
| info:pmid/23339018 |
